Dr. Wu is a seasoned executive with >20-years of experience in startup, established biotech, and large pharmaceutical companies. She is currently the Chief Scientific Officer and Senior Vice President of R&D, Fosun Pharma USA. Prior to joining Fosun Pharma in 2018, she was an Entrepreneur-in-Residence at Atlas Venture and Senior Vice President of Preclinical and Early Clinical Development at Delinia, which was acquired by Celgene in 2017. Prior to that, Dr. Wu held various senior leadership positions in the biotech and pharmaceutical industry including Vice President of Biology and Preclinical R&D at Concert Pharmaceuticals, Vice President of Discovery Research at Resolvyx Pharmaceuticals, Executive Director of Cardiovascular Research at the Novartis Institutes for BioMedical Research, and Director of Molecular and Cellular Pharmacology at Millennium Pharmaceuticals. Dr. Wu is an author of over 60 peer-reviewed publications, an inventor on a number of patents, and the recipient of Massachusetts High Tech’s “Women to Watch” award. She has been serving on the advisory council of IBBS/Johns Hopkins School of Medicine and is a member of JHU’s Society of Scholars. Dr. Wu received her Ph.D. in Biochemistry, Molecular Biology and Cell Biology from Northwestern University and completed a postdoctoral fellowship at Johns Hopkins University School of Medicine.